AI Article Synopsis
- The study investigates how long-term administration of albumin affects survival rates, recurrence of ascites, and other complications in patients.
- One hundred patients were divided into two groups: one received diuretics plus albumin, while the other received diuretics alone.
- Results showed that those receiving albumin had better survival rates and significantly lower chances of recurring ascites, with an average survival increase of 16 months.
Article Abstract
Aim: To investigate the effects of long-term albumin administration on survival, recurrence of ascites and onset of other complications.
Methods: One hundred consecutive patients admitted for first-onset ascites were randomized to receive diuretics plus human albumin 25 g/wk in the first year and 25 g every two wk thereafter (group 1) or diuretics alone (group 2). The primary endpoint was survival without liver transplantation. Secondary endpoints were recurrence of ascites and occurrence of other complications.
Results: Median follow-up was 84 (2-120) mo. Albumin-treated patients had significantly greater cumulative survival rate (Breslow test=7.05, P=0.0078) and lower probability of ascites recurrence (51% versus 94%, P<0.0001). Chronic albumin infusion resulted in a mean increase in survival of 16 mo.
Conclusion: Long-term albumin administration after first-onset ascites significantly improves patients' survival and decreases the risk of ascites recurrence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124318 | PMC |
| http://dx.doi.org/10.3748/wjg.v12.i9.1403 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!